Ceapro Reports First Quarter 2012 Financial Results and Provides a Corporate Update
(firmenpresse) - EDMONTON, ALBERTA -- (Marketwire) -- 05/28/12 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or "the Company") today released financial results for the quarter ended March 31, 2012 and provided a corporate update.
FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2012
"Our sales revenue and profits were lower in the first quarter versus last year and were the result of normal quarterly fluctuations", said Gilles Gagnon, Acting CEO of Ceapro. "Our results are best measured over the course of the entire year due to timing of orders and because different product mixes with different gross margins can have a big influence on quarterly results. Our operations in the quarter demonstrated solid operational performance while extra expenditures were required for launching a marketing study and to conduct a feasibility study related to manufacturing activities. We have continued to invest in our Company, our solid R&D program, and new technology to ensure Ceapro remains well noticed on the world innovation stage", added Mr. Gagnon.
CORPORATE UPDATE
Marketing and Sales:
New business:
Marketing strategy:
During the first quarter we launched a strategic marketing review to help determine the best way to increase the distribution and sales of Ceapro products across the globe. A US based company with exposure to the personal care industry was engaged to do a comprehensive review of our company and products, assess the markets, and determine the best strategy to grow. While we have successfully focused most of our limited resources on developing good products and processes as a sound foundation for success, it is now time to invest significantly in building out our marketing and sales network with the appropriate expertise to assist us in that regard. We will also take the opportunity to assess the branding of Ceapro.
Business Development:
Research and Development:
Our research and collaboration efforts have continued to generate positive news which we expect will translate into large gains in the future for Ceapro.
Avenanthramides:
Beta Glucan
Spearmint:
We have high expectations for this spearmint product for which we have obtained the rights for all indications from the University of Guelph. This is a great example of one plant that can produce several therapeutic products for several large markets that need solutions and represents a good example of how Ceapro may transition into the functional food or nutraceutical markets. It is also a great example of Canadian collaboration on the world stage and we expect this will be very beneficial for all the participants, and Canadian agriculture producers who may have opportunities to grow large volumes of a novel crop.
"As you can see, at Ceapro, we have a lot of exciting things to look forward in 2012 and beyond. The Ceapro team has worked very hard to develop these attractive growth opportunities and we anticipate this will result in increases in shareholder value", commented Mr. Gagnon.
The complete audited annual report and financial statements are available for review on SEDAR at and on the Company's website at .
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. To learn more about Ceapro, visit .
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Branko Jankovic
Vice President and CFO
Ceapro Inc.
Telephone (Edmonton): 780.917.8376
Email:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.05.2012 - 14:30 Uhr
Sprache: Deutsch
News-ID 1118353
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
EDMONTON, ALBERTA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 282 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ceapro Reports First Quarter 2012 Financial Results and Provides a Corporate Update
"
steht unter der journalistisch-redaktionellen Verantwortung von
Ceapro Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
